
Find out more about how timely shared decision-making discussions can help address unmet needs for women of childbearing age.
Professor Lars Erik Kristensen is Head of Research at the Parker Institute in Copenhagen, Denmark, and holds an honorary doctoral position at Lund University, Sweden, and a professorship at Copenhagen University, Denmark. He received his medical degree from Copenhagen University and a PhD in Clinical Medicine from Lund University. He later specialised in internal medicine and rheumatology. Professor Kristensen also completed a postdoc at Karolinska University, Sweden.
Professor Kristensen’s research interests are degenerative and inflammatory arthritis, with a focus on patient value, lifestyle factors, treatment response and predictors thereof in randomised controlled trials and observational settings. He also managed his own research group (South Swedish Arthritis Treatment Group [SSATG]) in Lund from 2011 to 2013. Professor Kristensen is also a board member and head of research at the Danish Society of Rheumatology. He has given >250 lectures at national and international congresses and meetings.
Find out more about how timely shared decision-making discussions can help address unmet needs for women of childbearing age.
Accompany Dr William Tillett and Dr Fabian Proft as they explore the approaches and challenges of managing D2T patients with PsA.
Achieving MDA or DAPSA treatment targets improves quality of life for patients with PsA.1–4 Explore the characteristics of patients who report treatment success...
ASDAS and BASDAI are commonly used in clinical practice.1,2 However, discover recent studies demonstrating that a high proportion of real-world patients do not...
Explore which treatment targets may be more appropriate for making treatment decisions in axSpA.
PsA and axSpA have overlapping disease manifestations which are driven by inflammation.1 Explore several extracellular cytokines that are implicated in these...